Periodic Reporting for period 1 - iMOTED (iMOTED Platform Built to improve Clinical Trial outcomes)
Reporting period: 2018-08-01 to 2018-12-31
Thanks to the development of IT tools, iMOTED can collect, integrate and validate clinical data from multicenter CT. The platform operates with real-time (RT) alarms to facilitate decision making, in case of unexpected results, allowing clinicians to make a quick and correct decision (e.g. human error, drugs interactions/toxicities).
iMOTED PHASE 1 OBJECTIVES
Task 1: Technical feasibility analysis.
Task 2: Commercial feasibility & Market study.
Task 3: Financial feasibility & Business Plan development.
COMMERCIAL FEASIBILITY STUDY: A detailed market analysis (value, forecast, segments, drivers, etc.) performed during iMOTED FS allowed us validating our market hypothesis and the market opportunity for our technology. We also defined the best go-to-market plan considering the features of our potential clients.
FINANCIAL FEASIBILITY STUDY: FS has also allowed us analyzing the funding requirements to bring iMOTED to the market and we also elaborate financial projections to determine the profitability of the project in different scenarios.